RNPC3 and neoplasm: We further evaluated the anti‐tumor efficacy of Trunc‐EBNA1‐RNP and Trunc‐EBNA3A‐RNP in a mouse tumor model using B16 cell lines stably expressing EBNA1 or EBNA3A (B16‐EBNA1 and B16‐EBNA3A) (Figure S4A, Supporting Information).